Target intelligence / Profile preview

Kelch-like ECH-associated protein 1-Nuclear factor erythroid 2-related factor 2 complex (KEAP1-NRF2)

Target
KEAP1-NRF2
Molecular classification
Transcription factor, E3 ubiquitin ligase substrate adapter, Protein-protein interaction
01

Overview

The KEAP1-NRF2 complex is the primary cellular mechanism for sensing and responding to oxidative and electrophilic stress. Kelch-like ECH-associated protein 1 (KEAP1) functions as a substrate adapter for the Cullin 3-based E3 ubiquitin ligase, which targets Nuclear factor erythroid 2-related factor 2 (NRF2) for proteasomal degradation under basal conditions (UniProt Q14145, Q16236). When cells encounter oxidative stress, reactive oxygen species (ROS) or electrophiles modify specific cysteine residues on KEAP1, disrupting the ubiquitination process. This allows NRF2 to accumulate, translocate to the nucleus, and bind to Antioxidant Response Elements (ARE) in the promoters of over 200 cytoprotective genes, including those for glutathione synthesis and detoxification enzymes (PubMed: 25911081). Pharmacological targeting of this complex aims to activate NRF2 to treat chronic inflammatory and degenerative diseases, such as chronic kidney disease and multiple sclerosis (PubMed: 30736422). However, the pathway is a double-edged sword; while it protects healthy cells, many cancers hijack NRF2 activation to survive oxidative stress and resist chemotherapy, making NRF2 inhibition a potential strategy in oncology (PubMed: 23435367).

Other names
KEAP1-NFE2L2 complexINRF2-NRF2 complexKEAP1-NRF2 signaling pathway
02

Mechanism of action

Inhibition of KEAP1-mediated ubiquitination of NRF2, leading to NRF2 stabilization, nuclear translocation, and activation of the antioxidant response element (ARE) gene battery.

03

Biological functions

Oxidative stress responseAntioxidant responseXenobiotic metabolismProteostasisInflammation regulationIron homeostasis
04

Disease associations

CancerNeurodegenerative diseaseChronic kidney diseaseInflammationCardiovascular diseaseDiabetesAutoimmune disease
05

Safety considerations

Pro-survival effects in established tumors (NRF2 addiction)Off-target reactivity of electrophilic activatorsPotential for cardiovascular toxicity (e.g., heart failure risk in bardoxolone trials)Potential for promoting chemoresistance in cancer cells
06

Interacting drugs

Bardoxolone methyl

6 more in the full profile.

07

Biomarkers

NQO1 (NAD(P)H quinone dehydrogenase 1) expressionHMOX1 (Heme oxygenase 1) expressionNRF2 nuclear localizationGCLC (Glutamate-cysteine ligase catalytic subunit) levelsGCLM (Glutamate-cysteine ligase modifier subunit) levels

Beyond the preview

Go deeper on Kelch-like ECH-associated protein 1-Nuclear factor erythroid 2-related factor 2 complex (KEAP1-NRF2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kelch-like ECH-associated protein 1-Nuclear factor erythroid 2-related factor 2 complex (KEAP1-NRF2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call